News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about CYBN
Recent news which mentions CYBN
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
These 10 Biotech Companies Are Researching 9 Different Psychedelic-Based Substances
August 22, 2025
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
MNMD
CMPS
ATAI
From
TalkMarkets
'Big 5" Psychedelic-Based Biotech Stocks Up 34% YTD
August 19, 2025
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
ATAI
GHRS
CMPS
From
TalkMarkets
Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming
June 03, 2025
Tickers
CYBN
Tags
Exclusives
Matthew Zorn
Benzinga
From
Benzinga
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
Psychedelics
Cannabis
CMPS
From
Benzinga
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday
February 13, 2025
Tickers
BROS
COOP
CSCO
CYBN
Tags
TXG
Benzinga
CSCO
From
Benzinga
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
November 29, 2024
Tickers
AACG
CMPS
CYBN
MNMD
Tags
CYBN
Market News
Recent Press Releases
From
Motley Fool
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
November 13, 2024
Tickers
CYBN
Tags
Benzinga
Cannabis
neuropsychiatry company
From
Benzinga
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
October 24, 2024
Tickers
CYBN
NEWS
Tags
General
Stories That Matter
CYBN
From
Benzinga
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
September 06, 2024
Tickers
AAWH
CCC
CYBN
NEWS
Tags
Market News
Cannabis executives
CYBN
From
Benzinga
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
August 09, 2024
Tickers
CYBN
Tags
Market News
Earnings Reports
NYSE:CYBN
From
InvestorPlace
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Tickers
ATAI
CMPS
CYBN
HAVLF
Tags
Kevin Bourke
CYBN
Market News
From
Benzinga
3 Biotech Stocks That Could Make Your Summer Unforgettable
July 30, 2024
Tickers
CYBN
GPCR
JEF
LLY
Tags
CYBN
JEF
NASDAQ:GPCR,NYSEAMERICAN:CYBN,NYSE:LLY,NASDAQ:SNDX,NYSE:JEF
From
InvestorPlace
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
July 03, 2024
Tickers
ATAI
CYBN
GHRS
Tags
CYBN
Stocks to Buy
Market News
From
InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
Tickers
ATAI
CMPS
CYBN
Tags
NASDAQ:ATAI,NASDAQ:CMPS,NYSEMKT:CYBN
Market News
Stocks to Buy
From
InvestorPlace
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
June 26, 2024
Tickers
CYBN
Tags
CYBN
NYSEMKT:CYBN
Earnings Reports
From
InvestorPlace
Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
June 26, 2024
Tickers
CYBN
Tags
Psychedelics
Market News
CYBN
From
Benzinga
Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More
June 18, 2024
Tickers
CURA
CURLF
CWBHF
CWEB
Tags
TLLTF
PLNH
TILT
From
Benzinga
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
June 05, 2024
Tickers
ATAI
CYBN
MDMA
MNMD
Tags
ETFs
ATAI
Top Stories
From
Benzinga
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
May 09, 2024
Tickers
ATAI
CMPS
CYBN
KAYS
Tags
CMPS
Cannabis
The Sacred Mushroom
From
Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Tickers
CMND
CMPS
CYBN
FLHLF
Tags
News
Benzinga
Psychedelics Research
From
Benzinga
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Tickers
CLNN
CYBN
LIFE
Tags
CYBN
CLNN
LIFE
From
InvestorPlace
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
TRUFF
ATAI
GHRS
From
Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
March 13, 2024
Tickers
CMPS
CYBN
MNMD
Tags
Benzinga
psilocybin therapies
Financing
From
Benzinga
3 High-Potential Penny Stocks to Turn $1000 into $1 million
March 10, 2024
Tickers
CYBN
GOEV
JOB
Tags
Market News
Stocks to Buy
NASDAQ:GOEV,NYSEMKT:CYBN,NYSEMKT:JOB
From
InvestorPlace
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
CYBN
Financing
Market News
From
Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
Tickers
CYBN
NEWS
Tags
Market News
Markets
CYBN
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
Psychedelic Research
MDXXF
IXHL
From
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Management
Europe Psychedelics
Australia Psychedelics
From
Benzinga
FDA Green Lights Cybin's Psychedelic Clinical Study Assessing Generalized Anxiety
January 23, 2024
Tickers
CYBN
NEWS
Tags
Benzinga
News
Market News
From
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics
IGXT
CMPS
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.